Microbiology Insights
A complete buyer’s guide for choosing EM vendors, media, air samplers, and software in pharma microbiology to ensure compliance and reliability.
Mrudula Kulkarni | Sep 22, 2025
Designing an EM Program – Locations, Frequency & Maps in the Pharmaceutical Microbiology Industry
Mrudula Kulkarni | Sep 22, 2025
USP <1116> – Alert/Action Levels & Trending in Pharmaceutical Cleanrooms
Mrudula Kulkarni | Sep 22, 2025
Other trending pieces on pharma manufacturing you may like to read
Sterility at the Source – Utilities & SUS in Contamination Control Strategy (CCS)
Discover how utilities and SUS form the backbone of sterility and CCS in pharma.
by Mrudula Kulkarni
Outsourcing & Tech Transfer within the CCS: Building Resilient Compliance in Pharma
Learn how robust CCS practices preserve sterility assurance through outsourcing, tech transfer, and global manufacturing partnerships.
by Mrudula Kulkarni
Bridging the Gap: CCIT’s Role in Complete Sterility Assurance
Discover how linking EM with CCIT transforms sterility assurance—bridging environmental control with product integrity.
by Mrudula Kulkarni
Understanding The 10 Key Micro Triggers That Lead To 483 Observations
Discover the top 10 microbiology triggers for FDA 483s and learn preventive measures to ensure regulatory compliance.
by Simantini Singh Deo
Annex 1 (2022–2023) — What Changed for Environmental Monitoring (EM) & Contamination Control Strategy (CCS) in Pharma Cleanrooms
Annex 1 introduces new rules for EM and CCS in cleanrooms, demanding continuous, risk-based monitoring and data-driven contamination control.
by Mrudula Kulkarni
